Ventricular arrhythmia risk due to chloroquine / hydroxychloroquine treatment for COVID-19: Should it be given
Main Author: | Amit Malviya |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2020-03-01
|
Series: | Indian Heart Journal |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S0019483220300791 |
Similar Items
-
Is it worth the wait? Should Chloroquine or Hydroxychloroquine be allowed for immediate use in CoViD-19?
by: Syed Shahzad Hasan, et al.
Published: (2020-03-01) -
Chloroquine and Hydroxychloroquine: Efficacy in the Treatment of the COVID-19
by: Tzu-Chuan Ho, et al.
Published: (2021-02-01) -
Nanomedicine Reformulation of Chloroquine and Hydroxychloroquine
by: David M. Stevens, et al.
Published: (2020-12-01) -
Predictors of Appropriate Shocks and Ventricular Arrhythmia in Indonesian with Brugada Syndrome
by: Ardian Rizal, et al.
Published: (2019-09-01) -
Hydroxychloroquine/chloroquine in patients with COVID-19 in Wuhan, China: a retrospective cohort study
by: Zhe Chen, et al.
Published: (2021-08-01)